Jia Jun's team was still conducting preclinical trials for Fengmu Tiada. It would be some time before they entered actual clinical trials, so they wouldn't need him for now.
The Hepatic Tumor Surgery department was also developing steadily, so he just needed to handle his regular specialist outpatient clinics.
Over in the emergency department, Wu Ting was now an associate chief physician and on third-line call duty. Under normal circumstances, he didn't need to get involved.
After some planning, Wu Ting decided to focus on the field of cardiac surgery next.
He was going to conquer Lou Musaang's surgery!
Wu Ting had already discussed it with Shen Siyuan and Director Shao Yuqiao. For now, the only option was to perform the first-stage vascular stent implantation for Lou Musaang. The procedure would use the fourth-generation bioresorbable polymer stent he had co-developed and produced with Weixing Petrochemical.
